Imeron

Iomeprol, the active ingredient in Imeron, is an iodinated contrast agent presented as a 350 mg I/mL injection solution for intravenous use. It enhances radiographic imaging in diagnostic procedures such as computed tomography, angiography, urography and venography. It is indicated for use in adult and pediatric patients undergoing contrast‑enhanced imaging, where improved delineation of vascular and organ structures is required.

GNH USA supplies Imeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide. The company ensures consistent quality, regulatory compliance and reliable logistics for global distribution.

Imeron (iomeprol) is an iodinated contrast agent used to improve X‑ray based imaging across several diagnostic procedures, delivering superior contrast enhancement and facilitating accurate clinical interpretation. - Contrast‑enhanced computed tomography: provides high‑contrast images of vascular and organ structures, aiding diagnosis. - Angiography: delineates blood vessels with enhanced radiopacity for accurate assessment and interventional planning. - Urography: enhances visualization of the urinary tract, facilitating detection of obstructions or lesions. - Venography: improves detection of venous pathology by increasing contrast between veins and surrounding tissues.

Imeron may be associated with a range of adverse reactions following intravenous administration.

Common Side Effects: - Warm sensation or flushing: transient feeling of heat or skin reddening. - Nausea or vomiting: mild gastrointestinal upset occurring shortly after injection. - Headache: temporary discomfort that usually resolves without treatment. - Mild urticaria or itching: limited skin rash that subsides spontaneously.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergic response that can include airway obstruction and shock. - Acute renal impairment: sudden decrease in kidney function, particularly in at‑risk patients. - Cardiovascular collapse: profound hypotension or arrhythmia requiring immediate medical intervention.

Before using Imeron, clinicians should observe several precautionary measures to reduce the risk of adverse events. - Assess renal function: evaluate serum creatinine and eGFR to determine suitability. - Review iodine allergy history: identify prior reactions to iodinated contrast media. - Ensure adequate hydration: encourage fluid intake before and after the procedure. - Use the lowest effective dose: tailor volume to the specific imaging study. - Monitor vital signs: observe blood pressure and heart rate during and after injection. - Store at ambient temperature: keep vials in original packaging, protect from light and moisture, and do not freeze.

Imeron can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid): - Cumulative iodine load: avoid concurrent use of other iodinated contrast agents. - Metformin in renal impairment: risk of lactic acidosis; consider temporary discontinuation. - Nephrotoxic drugs: concurrent aminoglycosides, NSAIDs or radiopharmaceuticals may increase kidney injury risk.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask tachycardia signs of contrast reaction. - Diuretics: can affect fluid balance and enhance renal stress. - Thyroid hormone therapy: excess iodine may alter thyroid function tests.